img logo ins

REPEC features

  • Any person can access the information included in REPEC freely and without charge.
  • All clinical trials authorized and non-authorized by OGITT are registered.
  • Registration is prospective and obligatory. It is one of the requirements to apply for a clinical trial authorization. Therefore, the Sponsor is responsible that information indicated during this registration is adequate and updated. This will allow fulfilling the goals set forth by our institution for transparency and improvement of public trust on research.
  • REPEC information fields comply with the minimum requirements of WHO trial registration data set and are available in Spanish and English. A model of the REPEC form used for the registration is available here.
  • More information about the 20 points of WHO data set or TRDS is available at: